Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Nike, Accolade And Other Big Stocks Moving Lower In Friday's Pre-Market Session
U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.2% on Friday.
美國股票期貨今天早上高開，納斯達克期貨週五上漲約0.2%。
Shares of NIKE, Inc. (NYSE:NKE) fell sharply in today's pre-market trading following fourth-quarter earnings and soft FY25 guidance.
NIKE股份有限公司（紐約證券交易所：NKE）在今天盤前交易中由於第四季度盈利和軟弱的FY25指引而大幅下跌。
Analysts at Stifel and Morgan Stanley downgraded the stock following the report.
斯蒂費爾和大摩資源lof的分析師在報告後調降了這支股票的評級。
NIKE shares dipped 15.6% to $79.42 in pre-market trading.
NIKE股價在盤前交易中下跌了15.6%，至79.42美元。
Here are some big stocks recording losses in today's pre-market trading session.
以下是在今天美股盤前交易中錄得下跌的一些大型股票。
- Accolade, Inc. (NASDAQ:ACCD) shares tumbled 32.1% to $4.34 in pre-market trading after the company reported first-quarter financial results and issued worse-than-expected FY25 revenue guidance. Also, Needham maintained a Buy rating on the stock but lowered its price target from $13 to $8.
- PTC Therapeutics, Inc. (NASDAQ:PTCT) shares slipped 13.5% to $30.00 in pre-market trading after the company said CHMP has issued negative opinion on renewal of conditional marketing authorization of Translarna (Ataluren) for the treatment of nmDMD.
- Kura Sushi USA, Inc. (NASDAQ:KRUS) shares declined 12.4% to $72.00 in pre-market trading after the company issued soft guidance.
- Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT) shares fell 12.4% to $18.75 in pre-market trading. The company announced the FDA issued a Complete Response Letter for the License Application For KRESLADI and requested limited additional Chemistry Manufacturing and Controls information to complete its review.
- Polestar Automotive Holding UK PLC (NASDAQ:PSNY) fell 7.7% to $0.7613 in pre-market trading after the company published full year 2023 results.
- Foot Locker, Inc. (NYSE:FL) shares fell 5.3% to $24.16 in pre-market trading.
- Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) shares declined 4.1% to $39.84 in pre-market trading. Apellis plans to seek re-examination following negative CHMP opinion for pegcetacoplan for geographic atrophy (GA) in the EU.
- Accolade股份有限公司（納斯達克：ACCD）週一在盤前交易中股價暴跌32.1%，每股股價爲4.34美元，此前該公司發佈了第一季度財務業績和比預期更差的FY25營收指引。同時，Needham對該股票維持買入評級，但將其目標價從13美元下調至8美元。
- PTC Therapeutics股份有限公司（納斯達克：PTCT）股票在盤前交易中下跌13.5%，至30.00美元，此前該公司表示CHMP對Translarna（Ataluren）治療nmDMD的條件性營銷授權續期發出了否定意見。
- Kura Sushi USA股份有限公司（納斯達克：KRUS）股票在盤前交易中下跌12.4%，至72.00美元，此前該公司發出了軟指引。
- Rocket Pharmaceuticals股份有限公司（納斯達克：RCKT）股票在盤前交易中下跌12.4%，至18.75美元，該公司宣佈FDA對KRESLADI的許可申請發出了完整的回應信，並要求提供有限的其他化學制備和控制信息以完成審核。
- Polestar Automotive Holding UK股份有限公司（納斯達克：PSNY）股票在盤前交易中下跌7.7%，至0.7613美元，此前該公司公佈了2023年全年業績。
- Foot Locker股份有限公司（紐約證券交易所：FL）在盤前交易中下跌了5.3%，至24.16美元。
- Apellis Pharmaceuticals股份有限公司（納斯達克：APLS）股票在盤前交易中下跌了4.1%，至39.84美元。Apellis計劃在收到歐盟地理性萎縮（GA）的pegcetacoplan的負面CHMP意見後尋求複審。
Now Read This: IZEA Worldwide And 2 Other Stocks Under $3 Insiders Are Buying
IZEA Worldwide和其他兩個股票都在3美元以下，內部人正在買入
Don't forget to check out our premarket coverage here
別忘了查看我們的盤前報道。
譯文內容由第三人軟體翻譯。